Gene Query: COL6A2

Dataset Description Geneva Score
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 134.5
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 129.45
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 129.45
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 125.43
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 123.27
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 112.61
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 100.47
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 98.3
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 98.3
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 96.38
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 86.65
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 85.39
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 84.77
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 84.77
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 84.01
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 83.5
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 80.52
IRF1 regulates IFN dependent and independent gene expression 80.1
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 79.18
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 75.06
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 74.59
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 73.39
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 72.38
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 72.34
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 70.45
Global analyses of the effect of different cellular contexts on microRNA targeting 70.45
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 67.64
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 67.6
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 67.6
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 67.11
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 66.68
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 66.19
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 65.24
The effect of PPARG inhibition on human angiomyolipoma cells 64.61
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 63.82
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 62.97
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 62.97
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 60.72
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 59.74
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 59.74
DJ-1 is dispensable for human stem cell homeostasis 59.69
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 59.38
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 59.0
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 59.0
RNA-seq of cells with TET1 knockout 58.78
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 58.61
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 57.99
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 57.87
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 57.87
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 56.38
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 56.07
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 54.78
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 54.47
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 53.51
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 52.86
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 52.03
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 51.78
RNA seq_PDX2_SHP099 51.71
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 51.6
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 51.15
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 50.91
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 50.91
MYCi975 regulates MYC target genes 49.13
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 48.92
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 48.82
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 48.69
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 48.59
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 48.14
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 47.69
Evolution of a transcriptional regulator from a transmembrane nucleoporin 46.83
RNA-seq in HepG2 and IMR90 cells 46.83
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 46.53
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 45.97
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 45.76
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 45.31
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 44.94
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 44.94
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 44.72
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 44.05
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 43.81
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 43.78
Investigation about fibroblasts of different origins in culture 43.65
RNA-seq of MCF10A cells and CAF 42.9
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 42.25
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 42.05
DIGIT regulates endoderm differentiation of human embryonic stem cells 41.85
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 41.77
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 41.45
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 41.17
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 41.15
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 41.15
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 40.82
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 40.58
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 40.32
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 40.03
Transcriptomic and gene ontology profiling of the human corneal cell types 39.67
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 39.51
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 39.51
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 39.16
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 39.07
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 38.36
Differentiation enhances Zika virus infection in neuronal brain cells 38.14
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 37.86
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 37.85
The Genomic Landscape of Atypical Fibroxanthoma 37.76
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 37.41
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 37.35
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 36.79
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 36.63
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 35.83
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 35.81
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 35.81
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 35.58
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 35.57
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 35.57
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 35.06
EWS-Fli and LNC regulated genes in comparison to GFP samples 35.01
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 34.72
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 34.43
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 34.33
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 34.31
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 34.3
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 34.01
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 33.85
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 33.68
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 33.14
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 33.01
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 32.58
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 32.49
Regionally specified human pluripotent stem cell-derived astrocytes 32.31
RNA-seq analysis of BAP1-depleted uveal melanoma cells 32.3
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 32.0
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 31.76
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 31.76
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 31.51
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 31.49
Modeling Human Cancer-induced Cachexia (Human) 31.43
RNA-seq analyses of human prostate cancer cells 31.39
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 31.22
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 31.22
Maturation of human iNSCs 31.1
Nucleoporin-mediated regulation of cell identity genes 31.02
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 30.58
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 30.58
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 30.34
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 30.29
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 30.24
Chromatin-informed inference of transcriptional programs in gynecologic cancers 30.24
Morphological and molecular characterization of human dermal lymphatic collectors 29.83
KLF6-dependent transcription in renal cancer cells 29.82
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 29.68
Identification of long noncoding RNAs regulated by p53 29.64
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 29.62
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 29.6
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 29.57
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 29.57
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 29.4
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 29.31
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 29.3
BI Human Reference Epigenome Mapping Project 29.29
Inhibition of TNBC metastasis by Gpx1 29.2
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 29.14
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 29.05
FOXD3 is a novel tumor suppressor in lung cancer 29.03
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 28.97
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 28.97
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 28.74
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 28.6
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 28.48
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 28.1
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 27.83
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 27.8
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 27.67
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 27.65
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 27.62
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 27.56
RNA-seq of human aneuploid cell lines with Trisomy 21 27.51
Rorc disruption in human FG pancreatic cancer cells 27.49
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 27.48
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 27.39
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 27.37
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 27.15
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 27.15
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 26.82
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 26.82
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 26.64
Gene expression patterns define the hepatocyte-like cells derived by different strategies 26.53
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 26.53
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 26.12
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 25.56
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 25.4
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 25.38
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 25.35
MEIS1 regulates hematopoiesis in hPSCs 24.89
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 24.61
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 24.54
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 24.53
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 24.53
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 24.53
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 24.25
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 24.03
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 24.02
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 24.01
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 23.91
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 23.89
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 23.77
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 23.73
Lineage specific differentiation is influenced by state of human pluripotency 23.64
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 23.64
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 23.64
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  23.57
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 23.48
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 23.37
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 23.25
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 23.18
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 23.18
High-Throughput Kinetic Analysis of Fractional Killing 23.17
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 23.16
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 23.01
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 22.86
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 22.8
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 22.74
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 22.71
iPSC derived motor neuron cultures from C9ORF72 carriers 22.7
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 22.68
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 22.52
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 22.26
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 22.26
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 22.13
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 21.99
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 21.86
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 21.48
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 21.45
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 21.45
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 21.34
Identification of Atrial Fibrillation associated genes and functional non-coding variants 21.26
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 21.25
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 21.15
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 21.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 20.88
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 20.85
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 20.75
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 20.56
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 20.45
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 20.43
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 20.42
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 20.39
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 20.26
Finding missing proteins from epigenetically manipulated human cells 20.22
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 20.14
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 20.14
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 20.11
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 20.11
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 20.11
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 20.07
The cytokine environment influence on human skin-derived T cells 20.0
Epigenomic landscape during organ formation in human early embryos 19.95
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 19.83
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 19.68
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 19.58
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 19.58
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 19.52
Role of FGFR1 in neuronal devlopment 19.28
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 19.22
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 19.21
Spliceosomal disruption of the non-canonical BAF complex in cancer 19.12
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 18.65
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 18.65
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 18.64
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 18.34
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 18.03
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 17.81
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 17.79
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 17.78
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 17.78
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 17.78
Transcription elongation regulates genome 3D structure 17.69
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 17.56
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 17.55
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 17.55
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 17.47
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 17.47
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 17.44
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 17.43
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 17.4
Gene expressions of H9s in different culture systems 17.29
ARID1A and ARID1B loss in HCT116 and TOV21G cells 17.29
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 17.21
Genome-wide Analysis of Chromatin Interactions in Human Cells 17.2
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 17.14
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 17.08
ARID1A regulates condensin II distribution and chromosomal partition 17.08
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 17.08
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 17.0
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 17.0
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 16.97
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 16.72
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 16.42
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 16.39
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 16.37
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 16.31
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 16.07
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 16.07
Total RNA sequencing of APC mutant and wt colonic organoids 15.99
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 15.99
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 15.93
CHCHD10 gene KO effect in iPSC drived motor neurons 15.93
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 15.88
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 15.85
SNHG5 siRNA knock down in HCT116 cells 15.61
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 15.26
IMP3 regulated gene expression in breast cancer cells 15.19
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 15.06
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 14.98
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 14.98
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 14.97
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 14.97
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 14.92
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 14.68
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 14.66
Neonatal and adult human testis defined at the single-cell level 14.61
Widespread regulated alternative splicing of single codons accelerates proteome evolution 14.56
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 14.55
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 14.55
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 14.5
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 14.35
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 14.04
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 13.96
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 13.96
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 13.83
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 13.81
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 13.57
Transcriptome of EBV-infected gastric cancer cell lines 13.54
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 13.53
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 13.46
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 13.43
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 13.37
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 13.36
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 13.02
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 12.97
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 12.8
An acquired vulnerability of drug resistant melanoma with therapeutic potential 12.5
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 12.5
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 12.07
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 11.97
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 11.86
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 11.81
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 11.61
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 11.61
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 11.45
Gene expression profile of human placenta from T. Cruzi infected mothers 11.29
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 11.21
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 11.14
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 11.14
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 10.77
Human ovarian granulosa cell transcriptome 10.76
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 10.65
RNA-seq analysis and shRNA screen of breast cancer 10.58
RNA-seq analysis of breast cancer 10.58
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 10.47
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 10.44
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 10.35
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 10.26
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 10.26
Gene profiling of human adult and pediatric liver cancer cells 10.09
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 10.08
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 10.08
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 10.03
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.78
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 9.75
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 9.55
RNA splicing alteration on glioblastoma and normal neural stem cells 9.49
Leucegene: ALL sequencing 9.43
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 9.39
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 9.38
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 9.25
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 9.2
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 9.16
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 9.15
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 9.12
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 9.06
The gene expression profiles of gallbladder cancer 9.05
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 8.91
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 8.91
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 8.8
Gene expression profile of CRC-derived HILEC 8.74
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 8.57
Identification of a LIF-responsive replication-competent human β cell 8.55
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 8.48
RNA seq with AML (NB4) cells upon FTO inhibition 8.32
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  7.82
The Glioma-Infiltrating T Cell Receptor Repertoire 7.7
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 7.7
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 7.7
Disruption of GRIN2B impairs differentiation in human neurons 7.67
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 7.54
Characterization of the Merkel cell carcinoma miRNome 7.48
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.46
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 7.43
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 7.43
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 7.36
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.35
CDK4/6 inhibitor resistance in prostate cancer 7.34
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.2
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 7.14
The DPYSL2 gene connects mTOR and schizophrenia 7.04
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 6.99
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 6.99
Transcriptome of activated human and mouse MAIT cells 6.8
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 6.8
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.73
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 6.56
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.54
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 6.47
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 6.44
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 6.38
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 6.36
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 6.15
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 6.09
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 6.09
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 6.05
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 6.02
The MEF2B Regulatory Network - RNA-seq data 6.01
The MEF2B Regulatory Network 6.01
Changes in human endometrial gland transcriptome over the window of implantation 6.0
Exogenous rescue of KLHL9 in SF210 cell line 5.94
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 5.88
Entrectinib Resistance in a Neuroblastoma Xenograft Model 5.87
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 5.85
Illumina HiSeq Sequencing on Breast cancer PDX samples 5.83
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 5.74
Total RNA sequencing of WT intestinal orgaonids. 5.69
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 5.63
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 5.63
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.63
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 5.31
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 5.31
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.31
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.31
MAIT cell RNA sequencing 5.18
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.99
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.99
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 4.71
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 4.71
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 4.71
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.7
CHCHD2 gene KO effect in iPSC drived motor neurons 4.6
Functional astrocytes differentiated from hiPSCs 4.5
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 4.36
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 4.26
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 4.13
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 4.11
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 3.82
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.69
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.69
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 3.56
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 3.56
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 3.45
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 3.26
RNAseq of Breast cancer PDX samples 3.18
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 3.07
RNA-sequencing 3.05
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 2.89
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 2.85
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.82
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.7
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 2.7
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.6
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 2.41
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.34
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.34
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.22
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.22
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.21
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.17
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.97
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.95
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 1.9
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.87
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.82
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 1.65
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 1.63
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.6
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 1.33
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.25
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.23
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.17
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 1.06
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 1.06
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.88
Transcriptomic analysis of human macrophages in 3D 0.83
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 0.58
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 0.54
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 0.47
mRNA sequencing of oropharyngeal cancer cell lines 0.47
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 0.34
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 0.34
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.34
Macrophage Ad5f35 PhenoMap 0.32
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.07


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation